Global Antimicrobial Susceptibility Testing Market to Reach USD 9.05 Billion by 2032 at 5.6 % CAGR - Antimicrobial Susceptibility Testing Forecast

According to a new report by Maximize Market Research, the global antimicrobial susceptibility testing market was valued at USD 5.85 billion in 2024 and is projected to reach USD 9.05 billion by 2032, growing at a CAGR of 5.6 % from 2025 to 2032. The forecast underscores escalating demand across hospitals, clinics, and diagnostic programs worldwide.

For full access to the data, request a sample report now :https://www.maximizemarketresearch.com/request-sample/1281/

♦Key Highlights

Market Size & CAGR: USD 5.85 billion in 2024, forecast to grow at a 5.6 % CAGR to reach USD 9.05 billion by 2032 .

Leading Segment: Manual antimicrobial .

Largest Region: North America dominated market share in 2024 and is anticipated to remain the fastest-growing regional market .

Key Drivers & Trends: Increased prevalence of infectious diseases, antibiotic resistance, innovative rapid AST methods, awareness initiatives on antimicrobial resistance .

Top Companies: Key players include bioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation, Bruker, Roche Diagnostics, Accelerate Diagnostics, Merck KGaA, Hi-Media Laboratories, Liofilchem, Alifax, Creative Diagnostics, Synbiosis, among around 25 total profiled .

♦ Market Outlook

The global antimicrobial susceptibility testing market is steadily expanding, underpinned by a growing need for accurate antimicrobial resistance profiling. Manual testing products-comprising susceptibility disks, MIC strips, and plates-remain the largest product segment due to affordability and widespread use, particularly in resource-limited settings . Meanwhile, novel rapid AST technologies are emerging to address the demand for faster diagnostics and higher precision.

♦ Regional Insights

In 2024, North America held the dominant share of the antimicrobial susceptibility testing market and is expected to sustain its leadership through 2032. Growth is propelled by advanced R&D efforts, technological innovations in AST systems, and heightened safety and regulatory focus. While not detailed in the summary, other regions such as Europe and Asia-Pacific are likely to benefit from rising antimicrobial resistance and healthcare investment trends reported in similar market analyses.

Gain more details with a free sample report. Inquire now :https://www.maximizemarketresearch.com/market-report/global-antimicrobial-susceptibility-testing-market/1281/

♦ Key Players

The competitive landscape includes market leaders and emerging entrants. Prominent companies like bioMérieux SA, Becton Dickinson, Thermo Fisher Scientific, Danaher, Bruker, Roche Diagnostics, Accelerate Diagnostics, and Merck KGaA are driving technological advancements (e.g., automated AST systems). Regional and niche players such as Hi-Media Laboratories, Liofilchem, Alifax, Creative Diagnostics, and Synbiosis expand the ecosystem through specialized offerings.

♦ Quote

"As antimicrobial resistance accelerates globally, the demand for reliable and rapid AST solutions underscores a critical timeline for innovation," said Dr. Asha Patel, Lead Healthcare Analyst at Maximize Market Research. "This forecast highlights both the urgency and opportunity in expanding AST technologies to support global health systems."

♦ Contact Us :

⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.

♣ About Us

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.